TickerFacts.

BioXcel Therapeutics, Inc. (BTAIQ): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$106.64M
Year ended 2021-12-31
2017-12-31: -$4.54M2018-12-31: -$19.95M2019-12-31: -$33.45M2020-12-31: -$82.11M2021-12-31: -$106.64M-$106.64M
2017-12-31 EBITDA (USD) 2021-12-31
Period endedEBITDAChange YoYSource filing
2021-12-31-$106.64Mn/m2023-03-16, From 2021-01-01
2020-12-31-$82.11Mn/m2022-03-11, From 2020-01-01
2019-12-31-$33.45Mn/m2021-03-12, From 2019-01-01
2018-12-31-$19.95Mn/m2020-03-09, From 2018-01-01
2017-12-31-$4.54Mn/a2019-03-12, From 2017-01-01